| Nazwa produktu: |
L-Carnitine orotate |
| Angielska nazwa |
L-Carnitine orotate; (r)-(3-carboxy-2-hydroxypropyl)-trimethyl ammonium orotate; Dl-/L-Carnitine Orotate; (2R)-3-Carboxy-2-hydroxy-N,N,N-trimethyl-1-propanaminium 1,2,3,6-tetrahydro-2,6-dioxo-4-pyrimidinecarboxylic acid salt; L-Carnitine orotic acid salt; 3-{[(2,6-dioxo-1,2,3,6-tetrahydropyrimidin-4-yl)carbonyl]oxy}-4-(trimethylammonio)butanoate; (2R)-3-carboxy-2-hydroxy-N,N,N-trimethylpropan-1-aminium 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxylate |
| MF |
C12H19N3O7 |
| Masie cząsteczkowej |
317.29516 |
| InChI |
InChI=1/C7H15NO3.C5H4N2O4/c1-8(2,3)5-6(9)4-7(10)11;8-3-1-2(4(9)10)6-5(11)7-3/h6,9H,4-5H2,1-3H3;1H,(H,9,10)(H2,6,7,8,11)/t6-;/m1./s1 |
| Nr CAS |
160468-17-7 |
| Struktury molekularnej |
|
| Symbole zagrożenia |
|
| Kody ryzyka |
|
| Bezpieczeństwo opis |
|
|
